Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
13096 | 860 | 31.1 | 45% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
455 | 3 | HEMOGLOBIN//SICKLE CELL DISEASE//SICKLE CELL ANEMIA | 25359 |
1642 | 2 | SICKLE CELL DISEASE//SICKLE CELL ANEMIA//ACUTE CHEST SYNDROME | 6938 |
13096 | 1 | ANTISICKLING ACTIVITY//ANTISICKLING AGENTS THERAPEUTIC USE//ANTISICKLING | 860 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ANTISICKLING ACTIVITY | authKW | 393282 | 1% | 92% | 12 |
2 | ANTISICKLING AGENTS THERAPEUTIC USE | authKW | 284038 | 1% | 100% | 8 |
3 | ANTISICKLING | authKW | 252477 | 1% | 89% | 8 |
4 | ANTI SICKLING AGENT | authKW | 147935 | 1% | 83% | 5 |
5 | HEMOGLOBIN S POLYMERIZATION | authKW | 147935 | 1% | 83% | 5 |
6 | ERYTHROCYTES DRUG EFFECTS | authKW | 142019 | 0% | 100% | 4 |
7 | SICKLE HEMOGLOBIN | authKW | 138569 | 1% | 35% | 11 |
8 | ANTISICKLING AGENT | authKW | 113614 | 0% | 80% | 4 |
9 | DEHYDRATION PREVENTION CONTROL | authKW | 113614 | 0% | 80% | 4 |
10 | PIRACETAM THERAPEUTIC USE | authKW | 113614 | 0% | 80% | 4 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Hematology | 6824 | 27% | 0% | 236 |
2 | Biochemistry & Molecular Biology | 1303 | 34% | 0% | 296 |
3 | Biophysics | 1283 | 15% | 0% | 127 |
4 | Integrative & Complementary Medicine | 280 | 2% | 0% | 20 |
5 | Medicine, Research & Experimental | 204 | 7% | 0% | 59 |
6 | Chemistry, Medicinal | 198 | 5% | 0% | 45 |
7 | Pharmacology & Pharmacy | 62 | 8% | 0% | 66 |
8 | Biology | 51 | 3% | 0% | 25 |
9 | Medicine, General & Internal | 30 | 5% | 0% | 39 |
10 | Microscopy | 25 | 1% | 0% | 6 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CNRS UA 607 | 71010 | 0% | 100% | 2 |
2 | MED CHEM QUAL CONTROL | 41222 | 1% | 19% | 6 |
3 | ABOJUPA LAYOUT | 35505 | 0% | 100% | 1 |
4 | ALBERT E EIN MED HEMATOL | 35505 | 0% | 100% | 1 |
5 | ATWATER S | 35505 | 0% | 100% | 1 |
6 | BIOL PL TECH | 35505 | 0% | 100% | 1 |
7 | CARDEZA FDN HERMATOLOGIC | 35505 | 0% | 100% | 1 |
8 | CARDIOVASC HLTH UNIT MONTPELLIER | 35505 | 0% | 100% | 1 |
9 | CARNDEZA FDN | 35505 | 0% | 100% | 1 |
10 | CELL MOLEC BIOL BIOPHYS CELL PHYSIOL | 35505 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BLOOD CELLS | 28157 | 3% | 3% | 23 |
2 | CLINICAL HEMORHEOLOGY | 14816 | 2% | 2% | 20 |
3 | TEXAS REPORTS ON BIOLOGY AND MEDICINE | 12153 | 1% | 5% | 7 |
4 | HEMOGLOBIN | 5084 | 2% | 1% | 18 |
5 | AMERICAN JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY | 4318 | 1% | 1% | 11 |
6 | BIOPHYSICAL JOURNAL | 3971 | 5% | 0% | 47 |
7 | JOURNAL OF MOLECULAR BIOLOGY | 2896 | 5% | 0% | 44 |
8 | AMERICAN JOURNAL OF HEMATOLOGY | 2863 | 3% | 0% | 22 |
9 | BLOOD | 2842 | 6% | 0% | 53 |
10 | JOURNAL OF LABORATORY AND CLINICAL MEDICINE | 2534 | 2% | 0% | 17 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | FERRONE, FA , (2016) SICKLE CELL DISEASE: ITS MOLECULAR MECHANISM AND THE ONE DRUG THAT TREATS IT.INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES. VOL. 93. ISSUE . P. 1168 -1173 | 28 | 70% | 0 |
2 | LU, L , LI, XJ , VEKILOV, PG , KARNIADAKIS, GE , (2016) PROBING THE TWISTED STRUCTURE OF SICKLE HEMOGLOBIN FIBERS VIA PARTICLE SIMULATIONS.BIOPHYSICAL JOURNAL. VOL. 110. ISSUE 9. P. 2085 -2093 | 28 | 62% | 0 |
3 | EATON, WA , HOFRICHTER, J , (1987) HEMOGLOBIN-S GELATION AND SICKLE-CELL DISEASE.BLOOD. VOL. 70. ISSUE 5. P. 1245-1266 | 56 | 57% | 249 |
4 | WANG, JC , KWONG, S , FERRONE, FA , TURNER, MS , BRIEHL, RW , (2009) FIBER DEPOLYMERIZATION: FRACTURE, FRAGMENTS, VANISHING TIMES, AND STOCHASTICS IN SICKLE HEMOGLOBIN.BIOPHYSICAL JOURNAL. VOL. 96. ISSUE 2. P. 655 -670 | 19 | 100% | 3 |
5 | TAM, MF , TAM, TCS , SIMPLACEANU, V , HO, NT , ZOU, M , HO, C , (2015) SICKLE CELL HEMOGLOBIN WITH MUTATION AT HIS-50 HAS IMPROVED SOLUBILITY.JOURNAL OF BIOLOGICAL CHEMISTRY. VOL. 290. ISSUE 35. P. 21762 -21772 | 27 | 59% | 1 |
6 | SAFO, MK , KO, TP , SCHREITER, ER , RUSSELL, JE , (2015) STRUCTURAL BASIS FOR THE ANTIPOLYMER ACTIVITY OF HB ZETA(2)BETA(S)(2) TRAPPED IN A TENSE CONFORMATION.JOURNAL OF MOLECULAR STRUCTURE. VOL. 1099. ISSUE . P. 99 -107 | 22 | 71% | 0 |
7 | SRINIVASULU, S , ACHARYA, AS , PRABHAKARAN, M , FABRY, ME , ALAMI, R , FIERING, SN , BOUHASIRRA, EE , NAGEL, RL , (2007) HBS-SAVARIA: THE ANTI-POLYMERIZATION EFFECT OF A SINGLE MUTATION IN HUMAN ALPHA-CHAINS.PROTEIN JOURNAL. VOL. 26. ISSUE 8. P. 523 -532 | 24 | 77% | 3 |
8 | FERRONE, FA , (2004) POLYMERIZATION AND SICKLE CELL DISEASE: A MOLECULAR VIEW.MICROCIRCULATION. VOL. 11. ISSUE 2. P. 115-128 | 24 | 75% | 30 |
9 | ADACHI, K , DING, M , ASAKURA, T , SURREY, S , (2009) RELATIONSHIP BETWEEN BETA 4 HYDROGEN BOND AND BETA 6 HYDROPHOBIC INTERACTIONS DURING AGGREGATE, FIBER OR CRYSTAL FORMATION IN OVERSATURATED SOLUTIONS OF HEMOGLOBIN A AND S.ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS. VOL. 481. ISSUE 2. P. 137-144 | 19 | 83% | 3 |
10 | ODER, E , SAFO, MK , ABDULMALIK, O , KATO, GJ , (2016) NEW DEVELOPMENTS IN ANTI-SICKLING AGENTS: CAN DRUGS DIRECTLY PREVENT THE POLYMERIZATION OF SICKLE HAEMOGLOBIN INVIVO?.BRITISH JOURNAL OF HAEMATOLOGY. VOL. 175. ISSUE 1. P. 24 -30 | 20 | 65% | 0 |
Classes with closest relation at Level 1 |